Splenectomy for hematologic disease. The UCLA experience with 306 patients

Area of Science:

• Hematology
• Surgical Oncology
• Immunology

Background:

• Splenectomy is a surgical procedure involving the removal of the spleen.
• Historically, splenectomy has been employed for various hematologic conditions and diagnostic staging.

Purpose of the Study:

• To evaluate the efficacy and safety of splenectomies performed for hematologic diseases.
• To assess the outcomes of therapeutic splenectomies for specific hematologic conditions.
• To determine the utility and risk of diagnostic splenectomies in Hodgkin's disease.

Main Methods:

• Retrospective review of 306 splenectomies performed between 1956 and 1981 at UCLA Medical Center.
• Analysis of therapeutic indications including anemia, thrombocytopenia, neutropenia, and splenomegaly.
• Evaluation of diagnostic splenectomies in patients with Hodgkin's disease.

Main Results:

• Over 75% of splenectomies were for therapeutic purposes.
• Excellent response rates were observed in idiopathic thrombocytopenic purpura (77%) and hereditary spherocytosis (90%).
• Good responses were also noted in autoimmune hemolytic anemias, Felty's syndrome, and hairy cell leukemia.
• Overall morbidity was 24% and mortality was 6%, with sepsis being the leading cause of death.

Conclusions:

• Therapeutic splenectomy provides significant palliative benefits in carefully selected patients with hematologic disorders.
• Diagnostic splenectomy in Hodgkin's disease is associated with a low risk, supporting its consideration.
• Splenectomy remains a valuable intervention for specific hematologic conditions and diagnostic staging.